What is the recommended management of amlodipine intoxication?

Management of Amlodipine Intoxication

For amlodipine overdose, immediately initiate vasopressors (norepinephrine preferred) and high-dose insulin therapy as first-line treatments, with early consideration of VA-ECMO for refractory shock, while avoiding intravenous lipid emulsion therapy which may worsen toxicity. 1, 2

Immediate Assessment and Monitoring

• Obtain a 12-lead ECG immediately and initiate continuous cardiac telemetry to detect QRS prolongation, bradycardia, hypotension, and conduction abnormalities. 2
• Measure blood pressure frequently, as amlodipine causes profound peripheral vasodilation with prolonged duration due to its long half-life (24-48 hours of toxicity). 2, 3
• Establish large-bore intravenous access for aggressive fluid resuscitation and rapid medication delivery. 2
• Monitor serum glucose every 15-30 minutes initially, then hourly once stabilized. 2
• Check ionized calcium, electrolytes (especially potassium), renal function, and creatine kinase serially. 2

First-Line Pharmacologic Management

Vasopressor Therapy (Class I Recommendation)

• Start norepinephrine immediately as the preferred vasopressor for amlodipine-induced hypotension; adult doses may require titration up to approximately 100 µg/min. 1, 2
• Vasopressors are readily available, act quickly, and should be initiated without delay. 1
• Epinephrine may be added or substituted if additional inotropic support is needed. 4, 2

High-Dose Insulin Therapy (Class I Recommendation)

• Initiate high-dose insulin therapy early for hypotension, either in conjunction with or refractory to vasopressors—this carries the strongest evidence (Class I, Level B-NR). 1, 4, 2
• Typical adult regimen: insulin 1 U/kg IV bolus, then continuous infusion starting at 0.5-1 U/kg/h, titrating up to approximately 10 U/kg/h as needed. 2
• Give an initial dextrose bolus (25-50 g) concomitantly with insulin and maintain continuous dextrose infusion (D10W or D5W at 100-200 mL/h) to keep glucose 100-200 mg/dL. 2
• High-dose insulin improves inotropy and has lower rates of vasoconstrictive complications than vasopressor-only therapy. 1
• Critical caveat: Use high-dose insulin cautiously in pure amlodipine overdose, as it is both an inotrope and vasodilator; it may theoretically worsen vasodilation if cardiogenic shock is not present. 3 Best used when some degree of myocardial dysfunction is suspected. 4, 3
• Monitor and aggressively replace potassium, as high-dose insulin frequently induces hypokalemia. 1, 2

Intravenous Calcium (Class I Recommendation)

• Administer calcium gluconate 3-6 g (30-60 mL of 10% solution) IV over 5-10 minutes; repeat every 15-20 minutes as needed. 1, 4, 2
• Target ionized calcium levels up to twice the normal range to enhance therapeutic effect. 1, 2
• Important limitation: Calcium alone is seldom sufficient; most patients will still require vasopressors and high-dose insulin. 1, 4

Management of Bradycardia

• Administer atropine 0.5-1 mg IV for hemodynamically significant bradycardia, though treatment failures are common. 1, 2
• Consider glucagon 3-5 mg IV bolus followed by infusion 2-10 mg/h for refractory bradycardia, though response rates are variable and vomiting is common. 1, 2
• Electrical pacing may be attempted for refractory bradycardia but is often ineffective, especially with complete AV-node blockade or severe vasodilatory shock. 1, 2

Refractory Shock Management

VA-ECMO (Class 2a Recommendation)

• Consider VA-ECMO early for shock unresponsive to maximal pharmacologic therapy, with reported survival rates approaching 77%. 1, 4, 2
• VA-ECMO is lifesaving for persistent cardiogenic shock (pump failure) refractory to maximal supportive care. 1
• Critical consideration: High flow rates may be needed to combat amlodipine-induced vasoplegia; central cannulation may be necessary to achieve adequate flows. 3, 5, 6
• Escalation to ECMO must be instituted early before irreversible multi-organ failure develops. 6

Adjunctive Therapies for Refractory Vasodilatory Shock

• Methylene blue (a nitric oxide synthase inhibitor) may be considered as an adjunct for refractory vasodilatory shock, though responses are mixed and effects may be transient. 1
• Albumin dialysis may enhance elimination of amlodipine given its high plasma protein-binding properties. 6

Intravenous Lipid Emulsion—NOT Recommended

• Do not routinely use intravenous lipid emulsion (ILE) for calcium-channel-blocker poisoning, as it may increase gastrointestinal absorption of lipophilic agents like amlodipine and worsen toxicity. 1, 2, 3
• A large retrospective study found no benefit from ILE therapy in CCB poisoning. 1
• ILE is specifically contraindicated as a Class 3 (No Benefit) recommendation. 2

Decontamination and Supportive Care

• Consider gastrointestinal decontamination (activated charcoal) in asymptomatic patients following potentially toxic ingestion if presenting within 1-2 hours. 4, 7
• Provide cardiovascular support including elevation of extremities and judicious fluid administration. 7
• Hemodialysis is not likely to be beneficial as amlodipine is highly protein-bound. 7

ICU Admission Criteria

Admit to intensive care unit if any of the following are present:

• Hypotension requiring vasopressor support. 2
• Bradycardia or significant conduction abnormalities. 2
• Altered mental status or coma. 2
• Ongoing need for high-dose insulin therapy. 2
• Ongoing seizures. 2

Key Clinical Pitfalls to Avoid

• Do not delay high-dose insulin therapy; it is the most effective intervention and should be started early alongside vasopressors. 2, 8
• Do not underestimate the prolonged effect of amlodipine; toxicity may persist for 24-48 hours, necessitating extended monitoring. 2, 3
• Do not use intravenous lipid emulsion for calcium-channel-blocker poisoning, as it may aggravate toxicity. 1, 2, 3
• Do not use flumazenil in polysubstance overdoses (if benzodiazepines, zolpidem, or ethanol co-ingested) due to heightened seizure risk. 2
• Recognize that amlodipine causes both cardiogenic and distributive shock through multiple mechanisms; tailor treatment to suspected shock etiology. 3
• Consult a medical toxicologist or poison center early for complex cases. 3